Table 3 Survival rates according to clinical and pathological data
From: HPV infection and p53 and p16 expression in esophageal cancer: are they prognostic factors?
Variable | Progression-free survival | Specific survival | ||||
|---|---|---|---|---|---|---|
Total events | One-year | p-value | Total events | One-year | p-value | |
Sex | ||||||
Female | 4 | 86.7 | 0.050 | 14 | 72.3 | 0.025 |
Male | 35 | 63.3 | 79 | 49.8 | ||
Age at diagnosis | ||||||
≤ 60 years old | 18 | 73.3 | 0.553 | 45 | 54.9 | 0.266 |
> 60 years old | 21 | 63.0 | 48 | 53.2 | ||
Alcohol consumption | ||||||
≤ 20 years | 5 | 74.6 | 0.218 | 16 | 62.0 | 0.301 |
> 20 years | 34 | 66.9 | 77 | 52.0 | ||
Tobacco consumption | ||||||
≤ 20 years | 11 | 51.3 | 0.158 | 19 | 49.0 | 0.796 |
> 20 years | 28 | 73.1 | 74 | 55.3 | ||
Clinical stagea | ||||||
I or II | 6 | 91.2 | 0.019 | 13 | 78.6 | <0.001 |
III or IV | 32 | 57.9 | 73 | 44.2 | ||
Histological gradea | ||||||
Well differentiated | 4 | 76.2 | 0.170 | 10 | 63.5 | 0.426 |
Moderately differentiated | 18 | 72.4 | 55 | 48.8 | ||
Poorly differentiated | 15 | 57.4 | 26 | 61.4 | ||
Surgery | ||||||
No | 32 | 65.8 | 0.486 | 84 | 47.5 | <0.001 |
Yes | 7 | 80.0 | 9 | 85.4 | ||
Chemoradiotherapy | ||||||
No | 8 | 72.4 | 0.731 | 24 | 34.6 | 0.039 |
Chemo or Radio | 15 | 62.3 | 36 | 47.7 | ||
Chemo and Radio | 16 | 72.9 | 33 | 69.1 | ||
HPVa | ||||||
Negative | 23 | 69.3 | 0.885 | 56 | 52.6 | 0.093 |
Positive | 3 | 71.4 | 11 | 31.3 | ||
p16a | ||||||
Negative | 35 | 66.9 | 0.956 | 84 | 52.4 | 0.739 |
Positive | 4 | 75.2 | 9 | 60.6 | ||
p53a | ||||||
Negative | 12 | 66.3 | 0.892 | 27 | 51.4 | 0.584 |
Positive | 26 | 67.0 | 63 | 54.9 | ||